MAFLD or MASLD: Which better represents the prognosis of the steatotic liver population: Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”

• Ying Wang,
• Shengfeng Wang,
• Xiude Fan,
• Jiajun Zhao,
• Yongfeng Song

Affiliations

Ying Wang

Department of Endocrinology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China

Shengfeng Wang

Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Haidian District, Beijing, China

Xiude Fan

Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education, Shandong First Medical University, Jinan, Shandong, China

Jiajun Zhao

Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education, Shandong First Medical University, Jinan, Shandong, China

Yongfeng Song

Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education, Shandong First Medical University, Jinan, Shandong, China